Skip to main content

Advertisement

Log in

Infectious diseases physician attitudes to long-term antibiotic use

  • Short Research Report
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

Abstract

Background In Australia, it is not known how much antibiotic prescribing by infectious diseases physicians is long-term, or how confident they are with the evidence behind this practice. Objective Survey Australian infectious diseases physicians to assess attitudes and prescribing practice prescribing prolonged courses of antibiotics. Methods An online questionnaire was distributed to the mailing group for the Australian Society of Infectious Diseases. Responses were collected from 29th October to 12th November 2015. Results The majority of respondents practiced in Australia as Infectious Diseases physicians, microbiologists, or trainees. 88% had prescribed long-term antibiotics. Heterogeneity was noted in the indications for prescription, including recurrent UTIs, cellulitis or chest infections, prosthetic joint infection and vascular graft infection. Beta-lactams antibiotics were prescribed most frequently. 22% of respondents had prescribed rifampicin/fusidic acid most frequently, while 11% could not identify a single antibiotic that they used most frequently, due to the heterogeneity of indications for prescribing. 95% stated that they would stop long-term antibiotic therapy if appropriate, and 74% were willing to enrol their patients into a randomised control trial looking at stopping long-term therapy. Conclusion Most infectious diseases physicians who responded to the survey prescribe long-term antibiotics, with great heterogeneity in the indications for which these antibiotics are prescribed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Goto N, Oka S. Pneumocystis jirovecii pneumonia in kidney transplantation. Transpl Infect Dis. 2011;13:551–8.

    Article  CAS  PubMed  Google Scholar 

  2. Dason S, Dason J, Kapoor A. Guidelines for the diagnosis and management of recurrent urinary tract infection in women. Can Urol Assoc J. 2011;5:316–22.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Stapleton A, Stamm W. Prevention of urinary tract infection. Infect Dis Clin North Am. 1997;11:719–33.

    Article  CAS  PubMed  Google Scholar 

  4. Jones P, Woolley I, Leder K, Spelman D, Cameron P, Cheng A. Postsplenectomy infection; strategies for prevention in general practice. Aust Fam Physician. 2010;39(6):383.

    PubMed  Google Scholar 

  5. Osman D, Berbari E, Berendt A, Lew D, ZImmerli W, Steckelberg J. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the infection diseases Society of Amrica. Clin Infect Dis. 2012;56(1):e1–25.

    Google Scholar 

  6. Baddour L. Long-term suppressive antimicrobial therapy for intravascular device-related infections. Am J Med Sci. 2001;322(4):209–12.

    Article  CAS  PubMed  Google Scholar 

  7. Lau J, Kiss C, Roberts E, Horne K, Korman T, Woolley I. Surveillance of life-long. antibiotics: a review of antibiotic prescribing practices in an Australian Healthcare Network. Ann Clin Microbiol Antimicrob. 2017;16:3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Survey Monkey, 2018. Available from: https://www.surveymonkey.com.

  9. Ozbug, 2018. Available from: www.asid.net.au/members/ozbug-2.

  10. Watson D. Ozbug: an email mailing list for physicians that works. Intern Med J. 2003;33(11):532–4.

    Article  CAS  PubMed  Google Scholar 

  11. Pushkin R, Iglesias-Ussel M, Keedy K, MacLauchlin C, Mould D, Berkowitz R, et al. A randomized study evaluating oral fusidic acid (CEM-102) in combination with oral rifampin compared with standard-of- care antibiotics for treatment of prosthetic joint infections: a newly identified drug–drug interaction. Clin Infect Dis. 2016;15(12):1599–604.

    Article  CAS  Google Scholar 

  12. Lau JSY, Korman TM, Woolley I. Life-long antimicrobial therapy: where is the evidence? J Antimicrob Chemother. 2018;73(10):2601–12.

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

No funding was received for this study.

Conflicts of interest

There are no conflicts of interest amongst those involved in the study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ian Woolley.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (14 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kiss, C.R., Lau, J.S.Y., Yeung, A. et al. Infectious diseases physician attitudes to long-term antibiotic use. Int J Clin Pharm 41, 18–21 (2019). https://doi.org/10.1007/s11096-018-00781-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-018-00781-4

Keywords

Navigation